°­¿ø´ëÇб³º´¿ø

½ºÅµ³×ºñ°ÔÀ̼Ç

°Ë»ö ¹Ù·Î°¡±â ÄÜÅÙÃ÷ ¹Ù·Î°¡±â ±Û·Î¹ú¸Þ´º ¹Ù·Î°¡±â ǪÅÍ ¹Ù·Î°¡±â

½ºÆÌ¸Þ´º

º´¿øÈ¨ ·Î±×ÀΠȸ¿ø°¡ÀÔ »çÀÌÆ®¸Ê

Àüü¸Þ´º

·¹ÇÁÆ® ¸Þ´º

Áø·á°ú/ÀÇ·áÁø
Áø·á°ú¾È³»
Áø·á°ú¾È³»
Àü¹®¼¾ÅÍ
Àü¹®¼¾ÅÍ
Ŭ¸®´Ð
Ŭ¸®´Ðº° ±¸ºÐ
  • Áø·á½Ã°£Ç¥
  • ¿À½Ã´Â±æ ¾È³»
  • Àå·Ê½ÄÀå ¾È³»

ÄÜÅÙÃ÷

ÇÁ¸°Æ®

»êºÎÀΰú

ÀÇ·áÁø¼Ò°³

Áø·áºÐ¾ß(Áúȯº°)

ºÐ¸¸, Á¦¿ÕÀý°³, Á¶±âÁøÅë, Á¶±â¾ç¸·ÆÄ¼ö, ´ÙÅÂÀÓ½Å, Àӽżº°íÇ÷¾Ð, Àӽżº ´ç´¢, ÀڱðæºÎ¹«·ÂÁõ, ŹÝÀÇ ÀÌ»ó, ¾ç¼ö°ú¼ÒÁõ, ¾ç¼ö°ú´ÙÁõ, ±âÇü¾Æ ¼±º°°Ë»ç ÀÌ»ó, »êÈÄÃâÇ÷, ³­ÀÓ(½ÃÇè°ü½Ã¼ú Æ÷ÇÔ), ½À°ü¼º À¯»ê, ÀڱñÙÁ¾, Àڱ󻸷Áõ, ¾ç¼º³­¼ÒÁ¾¾ç, ÀڱðæºÎÀü¾Ïº´º¯, HPV°¨¿°, ÀڱðæºÎ¾Ï, Àڱ󻸷¾Ï, ³­¼Ò¾Ï, º¹¸·¾Ï

Áø·áºÐ¾ß(Áõ»óº°)

ÀÓ½Å, ÀӽŰú °ü·ÃµÈ ÇÕº´Áõ, ³­ÀÓ, ÁúÃâÇ÷, ÁúºÐºñ¹°, ÇϺ¹Åë, º¹ºÎÆØ¸¸, »ý¸®Åë, »ý¸®ºÒ¼ø

Áø·áºÐ¾ß(À§Ä¡º°)

ÀÚ±Ã, ³­¼Ò, ³­°ü, Áú, ¿ÜÀ½ºÎ, ÇϺ¹ºÎ

¡Ø Àǻ纰 Áø·áºÐ¾ß°¡ »óÀÌÇÒ ¼ö ÀÖÀ¸¹Ç·Î Áø·á ¿¹¾à ½Ã Àü¹®ÁúȯÀ» È®ÀÎÇÏ¿© ¿¹¾à¹Ù¶ø´Ï´Ù.
  • ȲÁ¾À± ¼±»ý´Ô »çÁø
  • ¼º¸í
    : ȲÁ¾À±  
    Áø·á°ú
    : »êºÎÀΰú
    Àü¹®Áúȯ
    : ¸ð¼ºÅÂ¾Æ ÀÇÇÐ, ÃÊÀ½ÆÄ, º¹°­°æ ¼ö¼ú, ·Îº¿¼ö¼ú, Àڱó»½Ã°æ ¼ö¼ú, ÀڱñÙÁ¾, Àڱü±±ÙÁõ, ³­¼Ò ³¶Á¾, Àڱ󻸷Áõ
  • ÀÚ¼¼È÷º¸±â ¿­±â
  • ÇзÂ
    - Á¶¼±´ëÇб³ Àǰú´ëÇÐ ÀÇÇлç
    - ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ÀÇÇм®»ç
    - ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ÀÇÇйڻç
    °æ·Â
    - ¼­¿ï¾Æ»êº´¿ø ¼ö·ÃÀÇ
    - ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú Àü°øÀÇ/ÀÓ»ó°­»ç
    - °­¿ø´ëÇб³ Àǰú´ëÇÐ »êºÎÀΰú ÀüÀÓ°­»ç/Á¶±³¼ö/ºÎ±³¼ö
    - Stanford University Visiting scholar
    - °­¿ø´ëÇб³ º¸°ÇÁø·á¼ÒÀå
    - °­¿ø´ëÇб³ Àǰú´ëÇÐ/ÀÇÇÐÀü¹®´ëÇпø ÇлýºÎ¿øÀå
    - °­¿ø´ëÇб³ Àǰú´ëÇÐ/ÀÇÇÐÀü¹®´ëÇпø ¿øÀå
    - °­¿ø´ëÇб³º´¿ø ¾î¸°À̺´¿øÀå
    - Àü±¹ ±¹¸³´ë ¾î¸°À̺´¿øÀå ÇùÀÇȸ ȸÀå
    - Àü±¹ °íÀ§Çè »ê¸ð¡¤½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ ÇùÀÇȸ ȸÀå
    - (Çö) °­¿ø´ëÇб³º´¿ø °âÁ÷±³¼ö
    - (Çö) °­¿ø´ëÇб³º´¿ø °íÀ§Çè»ê¸ð¡¤½Å»ý¾ÆÅëÇÕÄ¡·á¼¾ÅÍÀå
    - (Çö) ºÐ¸¸Ãë¾àÁö ¾ÈÀüÇÑ Ãâ»ê ÀÎÇÁ¶ó ±¸Ãà »ç¾÷´ÜÀå
    - (Çö) Çѱ¹¸ðÀÚº¸°ÇÇÐȸ °£ÇàÀ§¿øÀå
    - (Çö) ´ëÇѸðüžÆÀÇÇÐȸ °íÇ÷¾Ð ¿¬±¸È¸ ȸÀå
    Àü¹®Áúȯ
    * Àü°øÁø·á(Áúȯº°) : ¸ð¼ºÅÂ¾Æ ÀÇÇÐ, ÃÊÀ½ÆÄ, º¹°­°æ ¼ö¼ú, ·Îº¿¼ö¼ú, Àڱó»½Ã°æ ¼ö¼ú, ÀڱñÙÁ¾, Àڱü±±ÙÁõ, ³­¼Ò ³¶Á¾, Àڱ󻸷Áõ
    * Àü°øÁø·á(Áõ»óº°) : Á¤»ó »ê¸ð °ü¸®, Á¶±âÁøÅë, Á¶±â ¾ç¸· ÆÄ¼ö, ÀӽŠÁßµ¶, ÅÂ¾Æ ±âÇü, ŹÝÀÌ»ó, »êÈÄ ÃâÇ÷
    * Àü°øÁø·á(À§Ä¡º°) : ¿©¼º ¿ÜÀ½ºÎ, Áú, ÀÚ±Ã, ³­¼Ò
    * Àü°øÁø·á(¼ú±â) : »ê¸ð Á¤¹ÐÃÊÀ½ÆÄ. ÀڱðæºÎ¹«·ÂÁõ¼ö¼ú,¾ç¼ö°Ë»ç, Á¦´ëÇ÷°Ë»ç. Á¶±âÁøÅëóġ, »êÈÄÃâÇ÷óġ, ·Îº¿¼ö¼ú
    ½Ã°£Ç¥
    ¿äÀÏ ¿ù È­ ¼ö ¸ñ ±Ý
    ¿ÀÀü   ¡Û    C    
    ¿ÀÈÄ    C    ¡Û   
    ¡Û : ¿Ü·¡Áø·á, C : Ŭ¸®´Ð
    ¡Ø9ÁÖ ÀÌ»ó ÀÓ»êºÎ´Â žÆÅ¬¸®´ÐÀ¸·Î ¿¹¾àÇϽñ⠹ٶø´Ï´Ù.
  • ÀÌÇâ¾Æ ¼±»ý´Ô »çÁø
  • ¼º¸í
    : ÀÌÇâ¾Æ  
    Áø·á°ú
    : »êºÎÀΰú
    Àü¹®Áúȯ
    : ºÒÀÓ, ½À°ü¼ºÀ¯»ê,°»³â±â, °ñ´Ù°øÁõ, ¼Ò¾ÆÃ»¼Ò³âºÎÀΰú
  • ÀÚ¼¼È÷º¸±â ¿­±â
  • ÇзÂ
    - ¿¬¼¼´ëÇб³ ¿øÁÖÀǰú´ëÇÐ ÀÇÇлç
    - ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ÀÇÇм®»ç
    - ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ÀÇÇйڻç
    °æ·Â
    - ¿¬¼¼´ëÇб³ºÎ¼Ó ¿øÁֱ⵶º´¿ø »êºÎÀΰú Àü°øÀÇ
    - ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú ÀÓ»ó°­»ç
    - ´ëÇѺ¸Á¶»ý½ÄÇÐȸ Á¤È¸¿ø
    - ¹Ì±¹ ½ºÅÄÆÛµå´ëÇб³ ¿¬¼ö
    - (Çö) °­¿ø¼­ºÎÇØ¹Ù¶ó±â¼¾ÅÍ ¼ÒÀå
    - (Çö) °­¿ø´ëÇб³º´¿ø °âÁ÷±³¼ö
    Àü¹®Áúȯ
    * Àü°øÁø·á(Áúȯº°) : ºÒÀÓ, ½À°ü¼ºÀ¯»ê,°»³â±â, °ñ´Ù°øÁõ, ¼Ò¾ÆÃ»¼Ò³âºÎÀΰú
    * Àü°øÁø·á(Áõ»óº°) : ¹«¿ù°æ, ¿ù°æ ÀÌ»ó, ¿ù°æ Àå¾Ö, °»³â±â ÁõÈıº, »çÃá±â ÀÌ»ó, ¼ºÁ¶¼÷Áõ
    * Àü°øÁø·á(À§Ä¡º°) : ¿©¼º ¿ÜÀ½ºÎ, Áú, ÀÚ±Ã, ³­¼Ò
    * Àü°øÁø·á(¼ú±â) : ºÒÀÓ°Ë»ç(¡Ø³²¼º ³­ÀÓ°Ë»ç(Á¤¾×°Ë»ç) Áø·á ÈÄ ¿¹¾à°¡´É), ¹è¶õÀ¯µµ, Àΰø¼öÁ¤, ü¿Ü¼öÁ¤, ¼Ò¾Æ û¼Ò³â °ñ¹Ý°Ë»ç, Æó°æ±âÈ£¸£¸ó¿ä¹ý
    ½Ã°£Ç¥
    ¿äÀÏ ¿ù È­ ¼ö ¸ñ ±Ý
    ¿ÀÀü   ¡Û   ¡Û   
    ¿ÀÈÄ ¡Û         
    ¡Û : ¿Ü·¡Áø·á, C : Ŭ¸®´Ð
  • ³ª¼ºÈÆ ¼±»ý´Ô »çÁø
  • ¼º¸í
    : ³ª¼ºÈÆ  
    Áø·á°ú
    : »êºÎÀΰú
    Àü¹®Áúȯ
    : °íÀ§ÇèÀÓ½Å, ÃÊÀ½ÆÄ, °ñ¹Ý³»½Ã°æ¼ö¼ú
  • ÀÚ¼¼È÷º¸±â ¿­±â
  • ÇзÂ
    - Ãæ³²´ëÇб³ ÀÇÇлç
    - ¿ï»ê´ëÇб³ ÀÇÇм®»ç
    - ¿ï»ê´ëÇб³ ÀÇÇйڻç
    °æ·Â
    - ¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ ¹× Àü°øÀÇ
    - ¼­¿ï¾Æ»êº´¿ø ÀÓ»ó°­»ç
    - °­¿ø´ëÇб³ Àǰú´ëÇÐ ÀÇÇаúÀå °â ÇлýºÎ¿øÀå °â °­¿ø´ëÇб³ º¸°ÇÁø·á¼Ò ¼ÒÀå
    - ¹Ì±¹ ºê¶ó¿îÀÇ´ë Visiting Professor
    - °­¿øÀÇ´ë »êºÎÀΰú ÁÖÀÓ±³¼ö
    - °­¿ø´ëÇб³º´¿ø »êºÎÀΰú °úÀå
    - °­¿ø´ëÇб³º´¿ø Áø·áÁö¿ø½ÇÀå
    - °­¿ø´ëÇб³º´¿ø ÀÇ·áÁú°ü¸®½ÇÀå
    - °­¿ø´ëÇб³º´¿ø ±âȹÁ¶Á¤½ÇÀå
    - °­¿ø´ëÇб³º´¿ø ¾î¸°À̺´¿øÀå
    - °­¿ø´ëÇб³º´¿ø Áö¿ªÈ¯ÀÚ¾ÈÀü¼¾ÅÍÀå
    - (Çö) °­¿ø´ëÇб³º´¿ø °âÁ÷±³¼ö
    ÇÐȸ
    - (Çö) ½ÄǰÀǾàǰ¾ÈÀüó ÀÇ·á±â±âÀÓ»óÀü¹®°¡
    - (Çö) ´ëÇÑ»êºÎÀΰúÇÐȸ ½É»çÀ§¿ø
    - (Çö) Çѱ¹ÀǾàǰ¾ÈÀü°ü¸®¿ø ÀǾàǰ ºÎÀÛ¿ë Àü¹®À§¿øÈ¸ Àü¹®°¡
    - (Çö) Çѱ¹ÀÇ·áºÐÀïÁ¶Á¤ÁßÀç¿ø ÀÇ·á»ç°í°¨Á¤´Ü ÀÚ¹®À§¿ø, ¿¹¹æÀ§¿ø
    - (Çö) ´ëÇѸðüžÆÀÇÇÐȸ À±¸®À§¿øÀå
    - (Çö) ¹ýÁ¦À§¿ø, ³«Å¹ýƯº°À§¿øÈ¸ À§¿ø, °íÀ§ÇèÀÓ½ÅÀ§¿øÈ¸ À§¿ø
    - (Çö) Àç´Ü¹ýÀÎ °Ç°ÏÇÑ¿©¼ºÀç´Ü »ç¹«ÃÑÀå
    - (Çö) ´ëÇÑÁÖ»êÀÇÇÐȸ Á¤º¸À§¿øÀå, °£ÇàºÎÀ§¿øÀå ¹× ±âȹÀ§¿ø
    - (Çö) Áß¾Ó¾à»ç½ÉÀÇÀ§¿øÈ¸ Àü¹®°¡
    - (Çö) Çѱ¹¸ðÀÚº¸°ÇÇÐȸ ÇмúÀ§¿ø
    - (Çö) ½Ä¾àó ÀÇ·áÁ¦Ç° ºÐ¾ß ±¹°¡Ç¥ÁØ(KS) Àü¹®À§¿ø
    Àü¹®Áúȯ
    * Àü°øÁø·á(Áúȯº°) : °íÀ§ÇèÀÓ½Å, ÃÊÀ½ÆÄ, °ñ¹Ý³»½Ã°æ¼ö¼ú
    * Àü°øÁø·á(Áõ»óº°) : Á¤»ó »ê¸ð °ü¸®, Á¶±âÁøÅë, Á¶±â ¾ç¸· ÆÄ¼ö, ÀӽŠÁßµ¶, ÅÂ¾Æ ±âÇü, ŹÝÀÌ»ó, »êÈÄ ÃâÇ÷
    * Àü°øÁø·á(À§Ä¡º°) : ¿©¼º ¿ÜÀ½ºÎ, Áú, ÀÚ±Ã, ³­¼Ò
    * Àü°øÁø·á(¼ú±â) : »ê¸ð Á¤¹ÐÃÊÀ½ÆÄ. ¾ç¼ö°Ë»ç, Á¦´ëÇ÷°Ë»ç. ÀڱðæºÎ¹«·ÂÁõ¼ö¼ú,Á¶±âÁøÅëóġ, »êÈÄÃâÇ÷óġ
    Àú¼úÁ¤º¸
    - ÀӽŰúÃâ»ê »çÀ̾𽺺Ͻº (2014)
    - ÁÖ»ê±âÀÇÇÐ-Áõ·Ê·Î ¹è¿ì´Â Áø´Ü°ú Ä¡·á ½ÅÈï¸Þµå½ÎÀ̾𽺠(2014)
    - ±âÇüžÆÀÇ ÃÊÀ½ÆÄ¿µ»ó µµÇØ µµ¼­ÃâÆÇ ±¸¾Ï (2015)
    - »ê°úÇÐ ±ºÀÚÃâÆÇ»ç (2015)
    - ¸ðŵ¶¼ºÇÐ : ÀÇ·áÀΰú µ¶¼ºÀü°øÀÚ¸¦ À§ÇÑ °¡ÀÌµå ±ºÀÚÃâÆÇ»ç (2016)
    - °íÀ§Çè ÀÓ»êºÎ¸¦ À§ÇÑ ¾È½É Ãâ»ê ÇÚµåºÏ ºÐ¸¸ Ãë¾àÁö ¾ÈÀüÇÑ Ãâ»ê ÀÎÇÁ¶ó ±¸Ãà»ç¾÷´Ü (2018)
    - ¸ÓÅ©¸Å´º¾ó Áø´Ü°ú Ä¡·á Á¦20ÆÇ ¹ø¿ª ½ÅÀϺϽº (2019)
    - »ê°úÇÐ ±ºÀÚÃâÆÇ»ç (2019)
    - Ãʱâ Àӽźθ¦ À§ÇÑ ¾È½É Ãâ»ê ÇÚµåºÏ ¾²¸®Ã¼¾î½º (2019)
    - Áõ·ÊÁ᫐ ¸ðüžÆÀÇÇÐ ±ºÀÚÃâÆÇ»ç (2020)
    - ÃÊÀ½ÆÄ ÀÌ»óžÆÀÇ Áø´Ü°ú »ó´ã ±ºÀÚÃâÆÇ»ç (2020)
    - Áß±â ÀÓ»êºÎ¸¦ À§ÇÑ ¾È½É Ãâ»ê ÇÚµåºÏ (ÁÖ) ¹Ù¶÷ (2020)
    - »êºÎÀΰúÇÐ ¿ë¾îÁý Áø±âȹ (2021)

    ½Ã°£Ç¥
    ¿äÀÏ ¿ù È­ ¼ö ¸ñ ±Ý
    ¿ÀÀü     ¡Û    C  
    ¿ÀÈÄ  C          
    ¡Û : ¿Ü·¡Áø·á, C : Ŭ¸®´Ð
    ¡Ø9ÁÖ ÀÌ»ó ÀÓ»êºÎ´Â žÆÅ¬¸®´ÐÀ¸·Î ¿¹¾àÇϽñ⠹ٶø´Ï´Ù.
  • ¾ÈÅÂ±Ô ¼±»ý´Ô »çÁø
  • ¼º¸í
    : ¾ÈÅÂ±Ô  
    Áø·á°ú
    : »êºÎÀΰú
    Àü¹®Áúȯ
    : ¸ð¼ºÅÂ¾Æ ÀÇÇÐ, ÃÊÀ½ÆÄ, °ñ¹Ý³»½Ã°æ¼ö¼ú
  • ÀÚ¼¼È÷º¸±â ¿­±â
  • ÇзÂ
    - °­¿ø´ëÇб³ ÀÇÇлç
    - °­¿ø´ëÇб³ ÀÇÇм®»ç
    °æ·Â
    - ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ÀÓ»ó°­»ç (¸ðüÅÂ¾Æ Àü°ø)
    - (Çö) °­¿ø´ëÇб³º´¿ø °âÁ÷±³¼ö
    - (Çö) °­¿ø´ëÇб³º´¿ø »êºÎÀΰúÀå
    Àü¹®Áúȯ
    * Àü°øÁø·á(Áúȯº°) : ¸ð¼ºÅÂ¾Æ ÀÇÇÐ, ÃÊÀ½ÆÄ, °ñ¹Ý³»½Ã°æ¼ö¼ú
    * Àü°øÁø·á(Áõ»óº°) : Á¤»ó »ê¸ð °ü¸®, Á¶±âÁøÅë, Á¶±â ¾ç¸· ÆÄ¼ö, ÀӽŠÁßµ¶, ÅÂ¾Æ ±âÇü, ŹÝÀÌ»ó, »êÈÄ ÃâÇ÷
    * Àü°øÁø·á(À§Ä¡º°) : ¿©¼º ¿ÜÀ½ºÎ, Áú, ÀÚ±Ã, ³­¼Ò
    * Àü°øÁø·á(¼ú±â) : »ê¸ð Á¤¹ÐÃÊÀ½ÆÄ, ¾ç¼ö°Ë»ç, Á¦´ëÇ÷°Ë»ç, ÀڱðæºÎ¹«·ÂÁõ¼ö¼ú, Á¶±âÁøÅëóġ, »êÈÄÃâÇ÷óġ
    ½Ã°£Ç¥
    ¿äÀÏ ¿ù È­ ¼ö ¸ñ ±Ý
    ¿ÀÀü  C          
    ¿ÀÈÄ   ¡Û    C    
    ¡Û : ¿Ü·¡Áø·á, C : Ŭ¸®´Ð
    ¡Ø9ÁÖ ÀÌ»ó ÀÓ»êºÎ´Â žÆÅ¬¸®´ÐÀ¸·Î ¿¹¾àÇϽñ⠹ٶø´Ï´Ù.
  • À̼¼Áø ¼±»ý´Ô »çÁø
  • ¼º¸í
    : À̼¼Áø  
    Áø·á°ú
    : »êºÎÀΰú
    Àü¹®Áúȯ
    : ¸ð¼ºÅÂ¾Æ ÀÇÇÐ, ÃÊÀ½ÆÄ, °ñ¹Ý³»½Ã°æ¼ö¼ú
  • ÀÚ¼¼È÷º¸±â ¿­±â
  • ÇзÂ
    - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÌÇлç
    - °­¿ø´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø Àǹ«¼®»ç
    - °­¿ø´ëÇб³ Àǰú´ëÇÐ ÀÇÇÐ¹Ú»ç ¼ö·á
    °æ·Â
    - °­¿ø´ëÇб³º´¿ø ÀÎÅÏ ¹× Àü°øÀÇ
    - ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ÀÓ»ó°­»ç (¸ðüÅÂ¾Æ Àü°ø)
    - (Çö) °­¿ø´ëÇб³º´¿ø °âÁ÷±³¼ö
    - (Çö) °­¿ø´ëÇб³º´¿ø »ê¸ðžÆÄ¡·áºÎÀå
    ÇÐȸ
    - ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ÆíÁýÀ§¿øÈ¸ °£»ç
    - Çѱ¹¸ðÀÚº¸°ÇÇÐȸ °£ÇàÀ§¿øÈ¸ °£»ç
    - ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ À繫À§¿ø
    - ´ëÇѸðüžÆÀÇÇÐȸ ¿ªÇבּ¸È¸ À§¿ø
    - ´ëÇÑ»êºÎÀΰúÇÐȸÁö(Obstet Gynecol Sci) ½É»çÀ§¿ø
    - ´ëÇÑÁÖ»êÀÇÇÐȸÁö ½É»çÀ§¿ø
    º»ÀμҰ³
    »ý¸íź»ýÀÇ ¼ø°£À» ÇÔ²² ÇÏ´Â »ê°ú ÀÇ»ç·Î¼­ Ã¥ÀÓ°¨°ú º¸¶÷Àº Àú¸¦ À̰÷ °­¿ø´ëÇб³º´¿ø »êºÎÀΰú¿¡ ¿À°Ô ¸¸µç ¿øµ¿·ÂÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÃʽÉÀ» ÀÒÁö ¾Ê°í, À̰÷¿¡¼­ ´õ Å« ²ÞÀ» ÀÌ·ç±â À§ÇØ ÃÖ¼±À» ´ÙÇÒ °ÍÀÔ´Ï´Ù.
    Àü¹®Áúȯ
    * Àü°øÁø·á(Áúȯº°) : ¸ð¼ºÅÂ¾Æ ÀÇÇÐ, ÃÊÀ½ÆÄ, °ñ¹Ý³»½Ã°æ¼ö¼ú
    * Àü°øÁø·á(Áõ»óº°) : Á¤»ó »ê¸ð °ü¸®, Á¶±âÁøÅë, Á¶±â ¾ç¸· ÆÄ¼ö, ÀӽŠÁßµ¶, ÅÂ¾Æ ±âÇü, ŹÝÀÌ»ó, »êÈÄ ÃâÇ÷
    * Àü°øÁø·á(À§Ä¡º°) : ¿©¼º ¿ÜÀ½ºÎ, Áú, ÀÚ±Ã, ³­¼Ò
    Àú¼úÁ¤º¸
    - Recent Trend about Pregnant Women with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) Infection, Perinatology, March, 2020;31(1)
    - Recent Advances in Uterine Myoma and Pregnancy, J Korean Soc Matern Child Health, 2020;24(3)

    ½Ã°£Ç¥
    ¿äÀÏ ¿ù È­ ¼ö ¸ñ ±Ý
    ¿ÀÀü ¡Û         
    ¿ÀÈÄ      C     C  
    ¡Û : ¿Ü·¡Áø·á, C : Ŭ¸®´Ð
    ¡Ø9ÁÖ ÀÌ»ó ÀÓ»êºÎ´Â žÆÅ¬¸®´ÐÀ¸·Î ¿¹¾àÇϽñ⠹ٶø´Ï´Ù.
  • ¹é¹ÎÇö ¼±»ý´Ô »çÁø
  • ¼º¸í
    : ¹é¹ÎÇö  
    Áø·á°ú
    : »êºÎÀΰú
    Àü¹®Áúȯ
    : »êºÎÀΰú ·Îº¿¼ö¼ú Àü´ã±³¼ö, ºÎÀÎ¾Ï (ÀڱðæºÎ¾Ï, Àڱ󻸷¾Ï, ³­¼Ò¾Ï), ÀڱñÙÁ¾, Àڱü±±ÙÁõ, Àڱ󻸷Áõ, Àڱ󻸷Æú¸³, ³­¼Ò¹°È¤
  • ÀÚ¼¼È÷º¸±â ¿­±â
  • ÇзÂ
    - ÇѾç´ëÇб³ ÀÇÇлç
    - ¿ï»ê´ëÇб³ ÀϹݴëÇпø ÀÇÇм®»ç
    - ¿ï»ê´ëÇб³ ÀϹݴëÇпø ÀÇÇйڻç
    °æ·Â
    - ÇѾç´ëÇб³ÀÇ·á¿ø ÀÎÅÏ
    - ÇѾç´ëÇб³ÀÇ·á¿ø Àü°øÀÇ
    - ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú ºÎÀÎÁ¾¾çÇÐ ÀÓ»ó°­»ç
    - ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú ºÎÀÎÁ¾¾çÇÐ ÀüÀÓ¿¬±¸¿ø
    - ÇѸ²´ë¼º½Éº´¿ø »êºÎÀΰú Á¶±³¼ö
    - ÇѸ²´ë¼º½Éº´¿ø »êºÎÀΰú ºÎ±³¼ö
    - (Çö) °­¿ø´ëÇб³º´¿ø »êºÎÀΰú ±â±Ý±³¼ö
    ÇÐȸ
    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ (KSGO) Áø·áÁöħÀ§¿øÈ¸ À§¿ø
    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ (KSGO) ÆíÁýÀ§¿øÈ¸ °£»ç (Àü)
    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ (KSGO) ¹ýÁ¦¼ÒÀ§¿øÈ¸ À§¿ø (Àü)
    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ (KSGO) ºÎÀξϵî·Ï¾÷ ¼ÒÀ§¿øÈ¸ À§¿ø (Àü)
    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ (KSGO) Áø·á±Ç°í¾È uterine cancer ÆÀ ¼ÒÀ§¿øÈ¸ À§¿ø (Àü)
    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ (KSGO) ±³°ú¼­ ¡®ºÎÀÎÁ¾¾çÇÐ Á¦2ÆÇ¡¯ ÁýÇÊÀ§¿øÈ¸ À§¿ø (Àü)
    - ±¹°¡¾ÏÁø·á°¡À̵å¶óÀÎ »ç¾÷´Ü ºÎÀÎ¾Ï Áø·á±Ç°í¾È ¼ÒÀ§¿øÈ¸ À§¿ø (Àü)
    - Associate Editor, JGO (Journal of Gynecologic Oncology)
    - ¾Æ½Ã¾ÆºÎÀÎÁ¾¾çÇÐȸ (ASGO) °¡ÀÓ·Â º¸Á¸ STF (Special Task Force)
    - ¾Æ½Ã¾ÆºÎÀÎÁ¾¾çÇÐȸ (ASGO) Scientific committee À§¿ø
    - ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ (KGOG) Tumor Site Committee, Cervix, Vulva, Vagina TSC À§¿øÈ¸ À§¿ø
    - ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ (KGOG) Tumor Site Committee, Uterine Corpus-GTT TSC À§¿øÈ¸ À§¿ø
    - ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ (KGOG) DSMB (Data Safety Monitoring Board) À§¿øÈ¸ À§¿ø
    - ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ (KGOG) SRB (Scientific Review Board) À§¿øÈ¸ °£»ç
    - ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ (KGOG) ±¹Á¦±³·ùÀ§¿øÈ¸ À§¿ø
    - ´ëÇÑÀÇÇÐÇмúÁöÆíÁýÀÎÇùÀÇȸ (KAMJE) Á¤º¸°ü¸®À§¿øÈ¸ À§¿ø
    - ´ëÇÑ»êºÎÀΰúÇÐȸ (KSOG) ¼ö·ÃÁ¦µµ¹ßÀü TFT ¼ú±â±³À° ±³¼ö (Àü)
    - ´ëÇÑ»êºÎÀΰú³»½Ã°æÇÐȸ (KSGENDO) Á¤º¸Åë½ÅÀ§¿øÈ¸ °£»ç (Àü)
    - ´ëÇѸ²ÇÁºÎÁ¾ÇÐȸ ¿¬±¸À§¿øÈ¸ À§¿ø (Àü)
    Àü¹®Áúȯ
    * Àü°øÁø·á(Áúȯº°) : »êºÎÀΰú ·Îº¿¼ö¼ú Àü´ã±³¼ö, ºÎÀÎ¾Ï (ÀڱðæºÎ¾Ï, Àڱ󻸷¾Ï, ³­¼Ò¾Ï), ÀڱñÙÁ¾, Àڱü±±ÙÁõ, Àڱ󻸷Áõ, Àڱ󻸷Æú¸³, ³­¼Ò¹°È¤
    * Àü°øÁø·á(Áõ»óº°) : °ñ¹ÝÅë, ÁúÃâÇ÷, ºÎÀΰú °ËÁø°á°ú ÀÌ»ó¼Ò°ß
    * Àü°øÁø·á(À§Ä¡º°) : ¿©¼º ¿ÜÀ½ºÎ, Áú, ÀÚ±Ã, ³­¼Ò
    * Àü°øÁø·á(¼ú±â) : ·Îº¿¼ö¼ú, º¹°­°æ¼ö¼ú, Àڱó»½Ã°æ¼ö¼ú (ÃÖ¼Òħ½À¼ö¼ú), ºÎÀΰú/ºÎÀÎ¾Ï ¼ö¼ú, Ç×¾ÏÈ­Çпä¹ý, ½Å¾àÄ¡·á¿ä¹ý
    Àú¼úÁ¤º¸
    [³í¹®]
    Author`s reply to: Cisplatin versus carboplatin?
    Baek MH, Park JY
    J Gynecol Oncol. 2025 Mar;36(2):e89.

    Clinical practice guidelines for uterine corpus cancer: an to the Korean Society of Gynecologic Oncology guidelines
    Hwang WY, Kim JH, Noh JJ, Baek MH, Choi MC, Lee YJ, Lee M, Suh DH, Kim YB, Kim DY
    J Gynecol Oncol. 2025 Jan;36(1):e71.

    Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer
    Baek MH, Chen L, Tekin C, Cristescu R, Jin XY, Shao C, Ihm SY, Jelinic P, Park JY

    Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement
    Kim JH, Kim DY, Kim J, Noh JJ, Hwang WY, Baek MH, Choi MC, Joo WD, Lee YJ, Suh DH, Kim YB
    J Gynecol Oncol. 2024 Mar;35(2):e45.

    Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)
    Park JY, Kim JH, Baek MH, Park E, Kim SW
    J Gynecol Oncol. 2022 Nov;33(6):e73.

    Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis.Baek MH, Park EY, Ha HI, Park SY, Lim MC, Fotopoulou C, Bristow RE.J Clin Oncol. 2022 May 20;40(15):1659-1670.

    Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study.Park JY, Lim MC, Baek MH, Park YH, Kim S.J Gynecol Oncol. 2021 Jul;32(4):e65.

    Feasibility and safety of fertility-sparing surgery in epithelial ovarian cancer with dense adhesion: a long-term result from a single institution.Baek MH, Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT.J Gynecol Oncol. 2020 Nov;31(6):e85.

    Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R)
    Choi MC, Chung YS, Lee JW, Kwon BS, Park BK, Kim SI, Shim SH, Lee KB, Seong SJ, Lee SJ, Lee SH, Yoo HJ, Song T, Kim MK, Baek MH, Kang S, Kim YM
    Eur J Cancer. 2020 Jul:133:56-65.

    The combination of histone deacetylase and p53 expressions and histological subtype has prognostic implication in uterine leiomyosarcoma
    Baek MH, Park JY, Park Y, Kim KR, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH
    Jpn J Clin Oncol. 2019 Aug 1;49(8):719-726.

    Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study.Baek MH, Kim DY, Kim SO, Kim YJ, Park YH.J Gynecol Oncol. 2018 Nov;29(6):e82.

    Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma
    Park JY, Baek MH, Park Y, Kim YT, Nam JH
    Virchows Arch. 2018 Jul;473(1):61-69.

    Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma.Baek MH, Park JY, Park Y, Kim KR, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.J Gynecol Oncol. 2018 May;29(3):e30.

    Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy
    Baek MH, Lee SW, Park JY, Rhim CC, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH
    Int J Gynecol Cancer. 2017 Mar;27(3):420-429.

    Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma
    Baek MH, Park JY, Rhim CC, Kim JH, Park Y, Kim KR, Nam JH
    Gynecol Obstet Invest. 2017;82(4):329-339.

    Incorporating a 3-dimensional printer into the management of early-stage cervical cancer
    Baek MH, Kim DY, Kim N, Rhim CC, Kim JH, Nam JH
    J Surg Oncol. 2016 Aug;114(2):150-2.

    Immunohistochemical Characterization of Histone Deacetylase as a Potential Prognostic Marker and Therapeutic Target in Endometrial Stromal Sarcoma
    Baek MH, Park JY, Rhim CC, Park Y, Kim KR, Kim JH, Nam JH
    Anticancer Res. 2016 May;36(5):2527-34.

    Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution
    Baek MH, Lee SW, Park JY, Kim D, Kim JH, Kim YM, Kim YT, Nam JH
    Int J Gynecol Cancer. 2015 Jan;25(1):69-74.

    Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer: long-term results at a single institution
    Baek MH, Lee SW, Park JY, Kim D, Kim JH, Kim YM, Kim YT, Nam JH
    J Korean Med Sci. 2014 Nov;29(11):1536-43.

    Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery
    Baek MH, Park JY, Kim D, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH
    Gynecol Oncol. 2014 Dec;135(3):462-7.

    Reliability of tumour grade 1 and endometrioid cell type on preoperative endometrial biopsy
    Baek MH, Park YR, Suh DS, Lee SW, Park JY, Kim D, Kim JH, Kim YM, Kim YT, Nam JH
    J Obstet Gynaecol. 2015 Jan;35(1):79-81.


    [¼ö»ó]
    - Best Reviewer Award, JGO (Journal of Gynecologic Oncology), ´ëÇѺÎÀÎÁ¾¾çÇÐȸ 2018

    - Best Reviewer Award, JGO (Journal of Gynecologic Oncology), ´ëÇѺÎÀÎÁ¾¾çÇÐȸ 2023

    - Best Reviewer Award, OGS (Obstetrics & Gynecology Science), ´ëÇÑ»êºÎÀΰúÇÐȸ 2024

    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ 2024³â Á¦39Â÷ Ãá°èÇмú´ëȸ º¸·ÉÇмú¿¬±¸ºñ»ó

    - ´ëÇѺÎÀÎÁ¾¾çÇÐȸ 2024³â Á¦8ȸ ºÎÀÎÁ¾¾çÀÇÇлó Çмú´ë»ó
    ½Ã°£Ç¥
    ¿äÀÏ ¿ù È­ ¼ö ¸ñ ±Ý
    ¿ÀÀü       ¡Û ¡Û 
    ¿ÀÈÄ ¡Û         
    ¡Û : ¿Ü·¡Áø·á, C : Ŭ¸®´Ð
À§·Î°¡±â

¹è³Ê

¿ì)24289 °­¿øÆ¯º°ÀÚÄ¡µµ Ãáõ½Ã ¹é·É·Î 156 °­¿ø´ëÇб³º´¿ø, ´ëÇ¥ÀüÈ­ 033-258-2000
copyright(c) 2010 KNUH.OR.KR ALL RIGHTS RESERVED.
°³ÀÎÁ¤º¸Ã³¸®¹æÄ§ À̸ÞÀÏÁÖ¼Ò ¼öÁý°ÅºÎ ȯÀڱǸ®ÀåÀü
º» »çÀÌÆ®´Â ÀÎÅÍ³Ý ÀͽºÇ÷η¯(IE11)¿¡ ÃÖÀûÈ­µÇ¾ú½À´Ï´Ù.